Adenosinergic Pathway: A Hope in the Immunotherapy of Glioblastoma

SIMPLE SUMMARY: Glioblastoma multiforme (GBM) is the most aggressive type of brain tumor with dismal survival and poor response to conventional therapies. Therefore, the development of immunotherapy for GBM treatment is necessary. However, the rigorous immunosuppression in the GBM-microenvironment (...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Ketao, Mao, Chunsen, Chen, Lin, Wang, Lude, Liu, Yuyao, Yuan, Jianlie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826839/
https://www.ncbi.nlm.nih.gov/pubmed/33435205
http://dx.doi.org/10.3390/cancers13020229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826839/
https://www.ncbi.nlm.nih.gov/pubmed/33435205
http://dx.doi.org/10.3390/cancers13020229

Ejemplares similares